AI will inflate healthcare costs before lowering them, Oz says

AI will “turbocharge” medical billing and drive up costs in the short term, CMS Administrator Dr. Mehmet Oz warned Wednesday. But he says the pain is worth it for long-term savings.

By Jill Hughes • Sept. 24, 2026

BD hires Arthur Hu as chief information and digital officer

BD predicted that Hu’s experience at Lenovo will be an important advantage as technology becomes increasingly central to how leading medtech companies operate.

By Nick Paul Taylor • Sept. 24, 2026

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

Agentic AI in MedTech: Driving efficiency and care outcomes

Agentic AI moves healthcare beyond reactive tools to orchestrate entire clinical workflows—improving efficiency and patient outcomes.

By Susmit Pal • Sept. 21, 2026

Mayo Clinic, Thermo Fisher partner to create Precure

The company will generate population-scale molecular data to inform development of diagnostics, therapies and other healthcare products.

By Nick Paul Taylor • Sept. 21, 2026

Cognita Imaging wins FDA contract to test LLMs in evaluating radiology AI

Cognita’s method will test a way of evaluating AI-generated radiology reports as the FDA considers how to regulate generative AI-enabled devices.

By Elise Reuter • Sept. 18, 2026

Healthcare’s agentic AI boom is outpacing governance: report

Patient safety could be at risk if agentic AI tools are rolled out without proper guardrails, Imprivata’s chief medical and growth officer warns.

By Jill Hughes • Sept. 18, 2026

ARPA-H to award $62.7M for AI in cardiovascular care

Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.

By Elise Reuter • Sept. 11, 2026

4 questions about the FDA’s approach to generative AI

The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.

By Elise Reuter • Sept. 9, 2026

Elucid raises $55M to commercialize cardiovascular imaging platform

Elucid, which gained a large medtech company as an investor, plans to grow industry partnerships as it looks to expand its AI-powered imaging platform.

By Nick Paul Taylor • Sept. 8, 2026

Vara receives CE mark for first autonomous breast cancer screening

The AI-enabled device can report screenings it determines are normal without radiologist review.

By Elise Reuter • Sept. 4, 2026

Vitestro secures FDA nod for robotic blood draw device

The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist shortage. 

By Nick Paul Taylor • Aug. 20, 2026

FDA seeks feedback on generative AI regulations

The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI for patient care.

By Elise Reuter • Aug. 19, 2026

FDA names second participant in TEMPO digital health pilot

Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.

By Elise Reuter • Aug. 17, 2026

From the clinic to the community: advancing healthcare innovation

See how Dell and NVIDIA are bringing AI-powered solutions to every point of care.

By Sandra Colner • Aug. 17, 2026

CHAI creates work group to counter frontier AI model cybersecurity risks

CHAI plans to create playbooks to help organizations defend against — and leverage — these powerful systems.

By Jill Hughes • Aug. 14, 2026

Medtronic on the future of AI-assisted surgery

Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.

By Susan Kelly • Aug. 5, 2026

Caristo wins FDA authorization for cardiovascular risk predictor

The University of Oxford spinout will soon launch the AI tool, which research suggests could help assess heart attack risk in patients who don’t have obstructive coronary artery disease.

By Nick Paul Taylor • Aug. 4, 2026

DeepHealth gets FDA nod for AI tool that reads ultrasounds, creates reports

DeepHealth’s tool automates lesion detection, characterization and reporting from breast ultrasound scans.

By Elise Reuter • Aug. 4, 2026

The FDA was all in on AI. Will that change?

High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.

By Kelly Bilodeau • July 29, 2026

Why Aidoc is taking a generative AI device to the FDA

Aidoc is bringing a system that can interpret images and make draft reports for radiologists to the FDA as the medtech industry awaits clarity on regulation of generative AI. Ensuring safety is paramount, said CEO Elad Walach.

By Elise Reuter • July 27, 2026

Medtronic adds real-time AI to Hugo robot

The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges Intuitive in the U.S. robotic soft tissue market.

By Susan Kelly • July 21, 2026

Top 10 medtech deals in the first half of 2026

Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.

By Nick Paul Taylor • July 6, 2026

HHS details takeaways from sweeping AI request for information

The healthcare sector wants the HHS to coordinate its AI strategy across agencies, provide implementation and governance support, and offer help in evaluating AI tools, leaders said Thursday.

By Emily Olsen • June 29, 2026

Aidoc wins breakthrough nod for AI that reads chest X-rays

Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.

By Elise Reuter • June 26, 2026

BD’s Bilal Muhsin talks AI in connected care

Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.

By Elise Reuter • Updated June 25, 2026